TCM
RETA
TimesSquare Capital Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-344,580
| Closed | -$35.1M | – | 182 |
|
|
2023
Q2 | $35.1M | Buy |
344,580
+341,180
| +10,035% | +$34.8M | 0.5% | 84 |
|
|
2023
Q1 | $309K | Buy |
+3,400
| New | +$309K | ﹤0.01% | 176 |
|
|
2020
Q3 | – | Sell |
-355,900
| Closed | -$55.5M | – | 250 |
|
|
2020
Q2 | $55.5M | Buy |
355,900
+145,000
| +69% | +$22.6M | 0.53% | 76 |
|
|
2020
Q1 | $30.4M | Buy |
+210,900
| New | +$30.4M | 0.36% | 123 |
|